ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.71
-0.78%
US Tech 100
21,524.40
0.41%
S&P 500
6,114.63
-0.01%
US Dollar vs CAD
1.41749
-0.10%
Bitcoin
96,250.01
0.09%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Nanobiotix (NANO) Share Price

Nanobiotix

Nanobiotix (NANO)

Nanoco Group Plc
Nano One Materials Corp
3.89
-0.06
(-1.52%)
Closed February 16 10:30AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
3.89
Bid
3.876
Ask
4.088
Volume
118,520
3.862 Day's Range 4.088
2.668 52 Week Range 7.01
Market Cap
135.473M
Previous Close
3.95
Open
3.998
Last Trade
33
@
3.89
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
114,400
Shares Outstanding
34,825,872
Dividend Yield
-
PE Ratio
-3.41
Earnings Per Share (EPS)
-1.14
Revenue
36.21M
Net Profit
-39.7M

About Nanobiotix

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.nanobiotix.com
Headquarters
Paris, Paris, Fra
Founded
-
Nanobiotix is listed in the Pharmaceutical Preparations sector of the Euronext with ticker NANO. The last closing price for Nanobiotix was 3.95 €. Over the last year, Nanobiotix shares have traded in a share price range of 2.668 € to 7.01 €.

Nanobiotix currently has 34,825,872 shares outstanding. The market capitalization of Nanobiotix is 137.56 € million. Nanobiotix has a price to earnings ratio (PE ratio) of -3.41.

Ask ADVFN Intelligence (AI)

NANO Latest News

More News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.3349.392575928013.5564.2983.5462524853.91230595DE
40.89629.92651970612.9944.2982.9821204233.65295449DE
120.298.055555555563.64.2982.6681144003.30523709DE
26-0.488-11.14664230244.3785.32.668793783.73071321DE
52-2.92-42.87812041126.817.012.668718134.44752701DE
156-3.69-48.68073878637.5810.41.6121194855.5649424DE
260-4.71-54.76744186058.617.341.6121169757.08191507DE

NANO - Frequently Asked Questions (FAQ)

What is the current Nanobiotix share price?
The current share price of Nanobiotix is 3.89 €
How many Nanobiotix shares are in issue?
Nanobiotix has 34,825,872 shares in issue
What is the market cap of Nanobiotix?
The market capitalisation of Nanobiotix is EUR 137.56M
What is the 1 year trading range for Nanobiotix share price?
Nanobiotix has traded in the range of 2.668 € to 7.01 € during the past year
What is the PE ratio of Nanobiotix?
The price to earnings ratio of Nanobiotix is -3.41
What is the cash to sales ratio of Nanobiotix?
The cash to sales ratio of Nanobiotix is 3.74
What is the reporting currency for Nanobiotix?
Nanobiotix reports financial results in EUR
What is the latest annual turnover for Nanobiotix?
The latest annual turnover of Nanobiotix is EUR 36.21M
What is the latest annual profit for Nanobiotix?
The latest annual profit of Nanobiotix is EUR -39.7M
What is the registered address of Nanobiotix?
The registered address for Nanobiotix is 60 RUE DE WATTIGNIES, PARIS, PARIS, 75012
What is the Nanobiotix website address?
The website address for Nanobiotix is www.nanobiotix.com
Which industry sector does Nanobiotix operate in?
Nanobiotix operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ALADOAdomos
0.57 €
(284,900.00%)
31.49k
MLSMLSmalto
0.02 €
(42.86%)
25.39k
ALCABCabasse SA
1.94 €
(22.78%)
43.16k
YOUNIYounited Financial SA
13.00 €
(18.18%)
146
VACBSPierre & Vacances
0.064 €
(16.36%)
24.78k
ALCYBCybergun
0.0001 €
(-50.00%)
106.7M
ALBOOBOOSTHEAT
0.0122 €
(-25.61%)
929.3k
BAIOdyssey Acquisition SA
0.21 €
(-25.27%)
986.4k
ETLEutelsat Communications
1.39 €
(-19.14%)
3.55M
ALOPMOncodesign Precision Medicine SA
0.42 €
(-14.29%)
72.51k
ATOAtos SE
0.0027 €
(8.00%)
954.9M
ALVERVergnet
0.0006 €
(0.00%)
265.64M
BCPBanco Comercial Portugues SA
0.5324 €
(3.70%)
144.83M
ALCYBCybergun
0.0001 €
(-50.00%)
106.7M
ALHPIHopium SA
0.0025 €
(-3.85%)
17.14M

Discussion

View Full Feed
ElementalArcher25 ElementalArcher25 4 minutes ago
I agree. I want the best price possible but if Naz can get an offer of 3 or more I would good with that but under 2 I would say wait but that's just mho.
ELTP
jour_trader jour_trader 9 minutes ago
Not necessarily. If R&D pipeline really is robust, we need time to execute. R&D pre-FDA filing isn't worth more than an FDA filing, which is less than an approved and launched product. R&D formulation lately has been slow to move due to all of the recent product launches, which is the reason to look
ELTP
janice shell janice shell 10 minutes ago
Yes? What "fraud" and "theft" have Musk and his proteges found? What they've bragged about finding?

Where's the proof? No one's seen any.
shurtha2000 shurtha2000 11 minutes ago
I'm expecting Fort Knox Audit to come up on a lot of missing gold -what happens to the price ? $$
Preciouslife1 Preciouslife1 12 minutes ago
https://www.mlb.com/news/giancarlo-stanton-dealing-with-sore-elbows-at-yankees-spring-training
silkmaster silkmaster 13 minutes ago
Well i hope that you will be able to change that target from 2029 back to 2025. based on news from KT and lab.

Less R&D news , yes the world of science will love it and it could help the share value years from now , but i think investors that are in Lt care less by now of what happe
KBLB
Whalatane Whalatane 13 minutes ago
Yes, the approval for a share buyback can expire, depending on the jurisdiction and the specific terms set by the company or its governing body.

United States: In the U.S., share buyback programs authorized by a company's board of directors typically do not have a statutory expiration
AMRN
ElementalArcher25 ElementalArcher25 13 minutes ago
Just remember the old saying a bird in the hand is better than 2 in the bush
ELTP
Preciouslife1 Preciouslife1 15 minutes ago
https://www.mlb.com/news/starling-marte-ready-to-contribute-for-mets-in-2025
jour_trader jour_trader 16 minutes ago
Likely the same result as Adderall IR & ER that were already crowded when Elite entered the market. We earned significant marketshare...
ELTP
jealmc79 jealmc79 19 minutes ago
" style="caret-color: rgb(29, 38, 46); color: rgba(29, 38, 46, 1); font-family: DMSans-Regular, sans-serif; font-size: 15px".i think they were built in Lam Dong..."
style="caret-color: rgb(29, 38, 46); color: rgba(29, 38, 46, 1); font-family: DMSans-Regular, sans-serif; font-size: 15p
KBLB
ElementalArcher25 ElementalArcher25 20 minutes ago
Yeah great ideal and what happens if 10 other generic drug makers get approved to manufacture Vyvanse over the next year?
ELTP
OMOLIVES OMOLIVES 21 minutes ago
Not sure...but these expenses are just being credited to the purchase price anyhow ;)
HMBL
newmedman newmedman 24 minutes ago
oh, coho is the tastiest fish I ever had. We cut the steaks up from the whale and they just don't shrink. It's seriously good fish. There's nothing else like it in my book, but I'm a bit of a homer. Waukegan harbor and I know each other very well.
asp42001 asp42001 25 minutes ago
Government E2E EBPP&H Common Sense!

USIO could help process, handle & verify government spending!

Follow digital money-trails, cut expenses...WIN-Win!

DEAL!
USIO
getmenews getmenews 25 minutes ago
Interesting, Japan been accumulating XRP, now they want to offer ETF's, wonder if Japan will unload once it's approved, which it shouldn't be unless it's traded as a security! HMM

Robinhood didn't allow traders to buy at .50, now traders can trade it again at 2.50? HMM

XRPUSD
norisknorewards norisknorewards 29 minutes ago
Must be a sign of the bottom if ya ask me based on this posters history

Exciting
NWBO
janice shell janice shell 30 minutes ago
That would be generally helpful. Yes, his work on EVs has been interesting, but hardly problem-free. The same can be said of SpaceX.

The work can be carried on by people who are not drama queens.
arizona1 arizona1 30 minutes ago
I wouldn't be surprised if he was more attracted to yours.
norisknorewards norisknorewards 31 minutes ago
Are you the regulatory expert on this board? Doubtful, like 99.99999% doubtful.

In my opinion, id only use trusted resources for information on the company and it's treatments.
NWBO
RichieBoy RichieBoy 31 minutes ago
Initiative gets noticed, whether required or not is irrelevant. ISO classification helps your company do more and earn more business. The entire process is more than worthwhile. It's a reassurance to your client base, regulators, prospective customers, investors, M&A candidates. Simply better busine
AFFU
janice shell janice shell 32 minutes ago
LOLOLOLOLOL!!
arizona1 arizona1 32 minutes ago
I just want him to die.
newmedman newmedman 32 minutes ago
i'm not sure if they counted, but I sent mine. 👀

Your Recent History

EU
NANO
Nanobiotix
USOTC
SYHBF
Skyharbour Resources (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads